Schoenberg Mark bought URGN
September 7, 2026 · Form 4 insider transaction
Schoenberg Mark bought 1,667 shares of UroGen Pharma Ltd., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,667
Price
N/A
Total value
N/A
InsiderSchoenberg Mark
Role—
CompanyUroGen Pharma Ltd. (URGN)
SecurityOrdinary Shares
Transaction codeM: Option exercise
Transaction dateSeptember 7, 2026
Filing dateSeptember 9, 2026
Shares owned after60,753
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.